|Bid||3.0000 x 900|
|Ask||3.3000 x 900|
|Day's Range||3.3000 - 3.3000|
|52 Week Range||2.6000 - 6.6400|
|Beta (3Y Monthly)||0.44|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 19, 2019 - Mar 25, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.55|
Every investor in ProPhase Labs, Inc. (NASDAQ:PRPH) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend Read More...
ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of over-the-counter dietary supplements (“ProPhase” or “Company”), announced today that Monica Brady has been promoted to the position of Chief Financial Officer. Ms. Brady has served as the Company’s Chief Accounting Officer since September 2017 and previously served as the Company’s Director of Finance since 2009. “We are pleased to announce Monica’s well-deserved promotion to Chief Financial Officer,” said Ted Karkus, Chairman and Chief Executive Officer of ProPhase.
ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of over-the-counter dietary supplements (“ProPhase” or “Company”), announced today that its Board of Directors has declared a special cash dividend in the amount of $0.25 per share on its common stock, payable on January 24, 2019 to stockholders of record as of January 10, 2019. This special cash dividend is the second such return of capital to stockholders this year, with a prior special dividend of $1.00 per share paid to ProPhase stockholders in June 2018. “We are very pleased to be able to reward our stockholders with this special cash dividend.
NEW YORK, Nov. 19, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
ProPhase Labs Inc (NASDAQ:PRPH), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is PRPH Read More...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on Aug. 20) Avanos Medical Inc (NYSE: AVNS ) Becton Dickinson and Co (NYSE: ...
After looking at ProPhase Labs Inc’s (NASDAQ:PRPH) latest earnings announcement (31 March 2018), I found it useful to revisit the company’s performance in the past couple of years and assessRead More...
NEW YORK, NY / ACCESSWIRE / March 21, 2018 / ProPhase Labs, Inc. (NASDAQ: PRPH ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 21, 2018 at 11:00 AM Eastern Time. ...